Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

OneSpan Inc. - Common Stock (NQ:OSPN)

16.05 +0.25 (+1.58%)
Streaming Delayed Price Updated: 3:44 PM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 230,245
Open 16.11
Bid (Size) 16.05 (3)
Ask (Size) 16.07 (4)
Prev. Close 15.80
Today's Range 15.81 - 16.11
52wk Range 12.51 - 20.36
Shares Outstanding 39,662,100
Dividend Yield 1.50%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
OneSpan to Announce Third Quarter Financial Results on October 30, 2025
From OneSpan Inc.
Via Business Wire
OneSpan Invests in ThreatFabric to Advance Fraud Prevention Innovation
From OneSpan Inc.
Via Business Wire

Performance

YTD
-14.8%
-14.8%
1 Month
+0.6%
+0.6%
3 Month
+6.5%
+6.5%
6 Month
+5.2%
+5.2%
1 Year
+10.9%
+10.9%

More News

Read More
OneSpan Inc (NASDAQ:OSPN) Emerges as a Peter Lynch-Style Investment Candidate
Via Chartmill
Earnings Scheduled For August 5, 2025
Via Benzinga
Earnings Scheduled For May 1, 2025
Via Benzinga
Earnings Scheduled For February 27, 2025
Via Benzinga
Sidoti Events, LLC's Virtual September Small-Cap Conference
Via ACCESS Newswire
OneSpan Inc (NASDAQ:OSPN) Emerges as a Strong Peter Lynch-Style Investment
Via Chartmill
OneSpan Inc. (NASDAQ:OSPN): A Peter Lynch-Style GARP Investment Candidate
Via Chartmill
OneSpan (OSPN) Fiscal Q2 EPS Jumps 16%
Via The Motley Fool
OneSpan Reports Second Quarter 2025 Financial Results
From OneSpan Inc.
Via Business Wire
OneSpan Inc (NASDAQ:OSPN) Fits Peter Lynch’s GARP Strategy with Strong Growth and Financial Stability
Via Chartmill
OneSpan to Announce Second Quarter Financial Results on August 5, 2025
From OneSpan Inc.
Via Business Wire
ONESPAN INC (NASDAQ:OSPN) – A GARP Candidate Worth Considering
Via Chartmill
ONESPAN INC (NASDAQ:OSPN) - A GARP Candidate Worth Considering
Via Chartmill
Sidoti Events, LLC's Virtual June Small-Cap Conference
Via ACCESS Newswire
OneSpan Accelerates FIDO Leadership With Acquisition Of Nok Nok Labs
From OneSpan Inc.
Via Business Wire
ONESPAN INC (NASDAQ:OSPN) - A GARP Candidate Worth Considering
Via Chartmill
OneSpan Announces Participation in Upcoming Investor Conferences
From OneSpan Inc.
Via Business Wire
OneSpan Reports First Quarter 2025 Financial Results
From OneSpan Inc.
Via Business Wire
Following Peter Lynch’s approach: Does ONESPAN INC (NASDAQ:OSPN) fit the bill?
Via Chartmill
OneSpan to Announce First Quarter Financial Results on May 1, 2025
From OneSpan Inc.
Via Business Wire
Why Peter Lynch may take an interest in ONESPAN INC (NASDAQ:OSPN)
Via Chartmill
OneSpan Reports Fourth Quarter and Full Year 2024 Financial Results
From OneSpan Inc.
Via Business Wire
Under the Radar: Uncovering Profitable, Undervalued Stocks
Via Benzinga

Frequently Asked Questions

Is OneSpan Inc. - Common Stock publicly traded?
Yes, OneSpan Inc. - Common Stock is publicly traded.
What exchange does OneSpan Inc. - Common Stock trade on?
OneSpan Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for OneSpan Inc. - Common Stock?
The ticker symbol for OneSpan Inc. - Common Stock is OSPN on the Nasdaq Stock Market
What is the current price of OneSpan Inc. - Common Stock?
The current price of OneSpan Inc. - Common Stock is 16.05
When was OneSpan Inc. - Common Stock last traded?
The last trade of OneSpan Inc. - Common Stock was at 10/24/25 03:44 PM ET
What is the market capitalization of OneSpan Inc. - Common Stock?
The market capitalization of OneSpan Inc. - Common Stock is 636.58M
How many shares of OneSpan Inc. - Common Stock are outstanding?
OneSpan Inc. - Common Stock has 637M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.